Experimental Study of WhaYoungJiTongTang(Heyingjitongtang)on the anti-angionesis

화영지통탕(和營止痛湯)의 혈관신생억제효과(血管新生抑制效果)에 관한 실험적(實驗的) 연구(硏究)

  • Kim, In-Seok (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Park, Joon-Hyuck (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Kang, Hee (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Kim, Sung-Hoon (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Yu, Young-Beob (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Shim, Bum-Sang (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Choi, Seung-Hoon (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University) ;
  • Ahn, Koo-Seok (Dept. of Oriental Pathology, College of Oriental Medicine, Kyung Hee University)
  • Published : 2001.12.30

Abstract

The purpose of this study is to prove the angiogenesis effects of WhaYoungJiTongTang (hereinafter referred to as the 'WYJTT'). For the study, by utilizing liver cancer cell line; SK-HEP-1, lung cancer cell line: A549, stomach cancer cell line: AGS and bovine capillary endothelial cell: BCE, the effects of the WYJTT on toxicity and proliferation ability of cells and the effects on anti-angiogenesis of bovine capillary endothelial cell and of mice's aorta were studied. 1. Cell viability assay In comparison with the control group, when $100{\mu}g/ml$ of WYJTT was injected, the viability was reduced in SK-Hep-1, $400{\mu}g/ml$ in A549 and $200{\mu}g/ml$ in AGS. 2. Cell proliferation assay In comparison with the control group, when $600{\mu}g/ml$ of WYITT was injected, DNA synthesis was reduced to 35.1% in the SK-Hep-1, 56.0% in A549, and 25.8% in BCE (bovine capillary endothelial cell); and when $400{\mu}g/ml$ was injected, DNA synthesis was reduced to 12.1 in AGS. 3. Tube formation assay In the event that BCE is injected with WYJTT in each of its content gradient, the anti-angiogenesis was effective in amounts of $400{\mu}g/ml$ with 6 hours of the treatment. 4. Aortic ring assay In comparison with the control group, the angiogenesis was restricted to the remarkable degree in amount of $200{\mu}g/ml$: 10% in $400{\mu}g/ml$; and fully inhibited in each of $800{\mu}g/ml$ and $1600{\mu}g/ml$. As a result of the experiments mentioned above, WYJTT showed its anti-angiogenesis effects against cancer cell line.

Keywords

References

  1. 경희대학교 대학원 석사학위논문 沒藥散이 혈관신생 억제에 미치는 효과에 대한 연구 姜大寅
  2. 경희대학교 대학원 석사학위논문 桂枝가 Angiogenesis의 억제기전에 미치는 영향 姜玧熙
  3. 경희대학교 대학원 석사학위 논문 加味慈桃丸의 angiogenesis 억제효과에 관한 실험적 연구 姜顯淑
  4. 增補 萬病回春 공延賢
  5. 경희대학교 대학원 석사학위논문 鬱金이 Angiogenesis 억제기전에 미치는 영향 成熙根
  6. 경희대학교 대학원 박사학위논문 扶正防癌湯이 암전이 억제에 미치는 영향 沈範相
  7. 慶熙大學校 대학원박사학위논문 加味慈桃丸 構成藥物의 血管新生抑制效果에 관한 硏究 王德仲;朴俊赫;劉永法;沈範相;安圭錫;崔昇勳
  8. 대전대학교 대학원 박사학위논문 桃紅四物湯加減方의 항암 및 항전이 효과에 관한 연구 趙漢震
  9. 大韓韓醫學會誌 v.8 no.2 Hydrocortisone acetate로 誘發된 瘀血病態model에 關한 硏究 金聖洙
  10. 97국제어혈심포지움 논문집 수종어혈약물의 배합에 의한 抗癌 및 癌轉移 효과에 대한 연구 金聖勳;김동희
  11. 加味金궤腎氣丸의 抗癌및 抗轉移 效果에 關한 硏究 김용래;김성훈(외)
  12. 제2차 세포주 연구 워크숍 Invasion and angiogenesis assay 김우호
  13. 臟腑辨證論治 金完熙;崔達永
  14. 대한동의학회지 v.11 no.1 도인승기탕 및 그 구성약물이 어혈병태모형에 미치는 영향 김정범(외)
  15. 연세의대논문집 v.11 no.1 암면역학 金鎭福
  16. 대한의학회지 v.21 no.7 장기이식면역학 및 종양면역학 金鎭福
  17. 病態生理學 金昌種
  18. 대한한의학회지 v.10 암의 치료 치방에 관한 문헌적 고찰 金韓燮 등
  19. 활락효령단이 Angionesis억제기전에 미치는 영향 나기환
  20. 병리학
  21. 東醫病理學 文濬典;安圭錫;崔昇勳
  22. 東醫病理學(1) 文濬典;安圭錫;崔昇勳
  23. 인간생명과학 박재갑
  24. 中華腫瘤雜誌 v.3 no.3 丹蔘이 腫瘤의 生長과 轉移에 미치는 迎香과 그 원리에 대한 초보적 探討에 관한 실험 傅乃武
  25. 腫瘍學
  26. 개정판 종양학
  27. 韓方婦人科學 宋炳基
  28. 實驗的 肝瘀血에 미치는 桂枝茯笭丸 및 그 加味方의 效果에 관한 硏究 申鎭湜
  29. 中醫臨床手冊
  30. 中國醫藥學報 v.2 no.1 八十年代中醫藥物治療腫瘤進展 楊維益
  31. 醫林改錯 王淸任
  32. 十全大補湯이 癌轉移 抑制에 미치는 영향 윤재호
  33. 입안산이 Angiogenesis억제기전에 미치는 영향 이기룡
  34. 本草學 李尙仁
  35. 제3의학 v.3 no.1 Angiogenesis의 한의학적 치료전략 이준우;최승훈;안규석
  36. 대한한방종양학회지 v.1 no.1 종양의 병인병리에 대한 문헌적 고찰 전병욱;유봉하;박동원;유기원
  37. 傷科補要 卷三 湯歌 錢秀昌
  38. 醫門寶鑑 周命新
  39. 病理學
  40. 東醫腫瘍學 崔昇勳
  41. 대한한방종양학회지 v.1 no.1 한의학의 腫瘍에 대한 인식과 병리론 崔昇勳
  42. 암예방 및 치료를 위한 한의학적 연구
  43. J Bio Chem, v.267 Angiogenesis Folkman, J.;Shing, Y.
  44. Lancet v.339 Biology of tumor metastasis Hart, I.R.;Saini, A.
  45. J. Immuno. v.134 Lysis of human solid tumor cell by Iymphokine-activated natural killer cells Itoh, K.(et al)
  46. Cell. v.79 Angiostatin:A Novel Angiogenesis Inhibitor That Mediates the Suppression of Metastases by a Lewis Lung Carcinoma. Michael, S.(et al)
  47. J Immunol Method, v.65 no.1-2 T Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays Mosmann
  48. Biochem. Biophys. Res. Comm. Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor Oikawa, T.(et al)
  49. Cell v.88 an endogenous inhibitor of angiogenesis and tumor growth. 0'Reilly,(et al)
  50. Science v.261 Human c-myc transcription factor PuF identified as nm23-H2 necleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Postel, E.H.;Berberich, S.J.;Flint, S.J.;Ferrone, C.A.
  51. J Cell Physiol v.156 no.2 Type Ⅳ collagenase and TIMPs modulate endothelial cell morphogenesis in vitro. Schnaper, H.W.(et al)
  52. Am J Pathol v.152 no.2 Activation of coagulation and angiogenesis in cancer:immunehistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer Shoji, M.(et al)
  53. Cancer Invasion and Metastases Sugarbaker, E.V.;Weingard, D.N.;Roseman, J.M.;Liotta, L.A.;Hart, I.R.(ed.)
  54. Exp. Pathol Inhibitory effects of antiangiogenic agents on neovascularization Tanaka, N.G.;Sakamoto, N.;Tohgo, A.;Nishiyama, Y.;Ogawa, 0.
  55. Int J Cancer v.75 no.5 Vaschular endothelial growth factor induces tissue factor and matrix metaltoproteinase production in endothelial cells:conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Zucher, S.;Mirza, H.;Conner, C.E.;Lorenz, A.F.;Drews, M.H.;Bahou, W.F.;Jesty, J.